Phoebe E. Harvey

Hematology | Oncology
3600 N Interstate Ave
Portland, OR 97227

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Zanidatamab plus palbociclib and fulvestrant in previously treated patients with hormone receptor-positive, HER2-positive metastatic breast cancer: primary results from a two-part, multicentre, single-arm, phase 2a study.

Zanidatamab plus palbociclib and fulvestrant in previously treated patients with hormone receptor-positive, HER2-positive metastatic breast cancer: primary results from a two-part, multicentre, single-arm, phase 2a study.

Journal: The Lancet. Oncology
Published: October 14, 2024
Showing 1-1 of 1

Last Updated: 09/26/2026